Does a dedicated nurse practitioner improve thromboprophylaxis use in acutely ill medical patients in Australia? The methodology for a multicentre VTE task force audit

International Angiology

Volumn 28, Issue 1, 2009, Pages 73-78

  Gibbs, H ^a   Fletcher, J P ^b   Blombery, P ^c   Glennane, A ^d   Collins, R ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d Sanofi Aventis   (Australia)

Author keywords

Prophylaxis; Pulmonary embolism; Thromboembolism; Venous thrombosis

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; EDUCATION PROGRAM; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HEALTH EDUCATOR; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MULTICENTER STUDY; NURSE PRACTITIONER; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; CRITICAL ILLNESS; MULTICENTER STUDY (TOPIC);

ACUTE DISEASE; AUSTRALIA; CLINICAL AUDIT; CRITICAL ILLNESS; HUMANS; MULTICENTER STUDIES AS TOPIC; NURSE PRACTITIONERS; VENOUS THROMBOEMBOLISM;

EID: 65749086646     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [guidelines]. Chest 2004;126(3 Suppl);338S-400S.
2. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Con sensus Statement (guidelines according to scientific evidence) [consensus statement]. Int Angiol 2006;25:101-61.
3. Francis CW. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 2007;356:1438-44.
4. The Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Prevention of venous thromboembolism: best practice guidelines for Australia and New Zealand [guidelines]. 3rd ed. Sydney: Health Education and Management Innovations; 2006.
5. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J Royal Soc Med 1989;82:203-5.
6. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302:709-11.
7. Peterson GM, Drake CI, Jupe DML, Vial JH, Wilkinson S. Educational campaign to improve the prevention of postoperative venous thromboembolism. J Clin Pharm Ther 1999;24:279-87.
8. Eikelboom JW, Mazzarol, A, Quinlan DJ, Beaver R, Williamson J, Yi Q, et al. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. Haematologica 2004;89:586-93.
9. Wan S, Ting J, Olsen A, Croser J, Eikelboom JW. Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia. ANZ J Surg 2003;73:826-9.
10. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalised patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000;118:1680-4.
11. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol 1997;50:609-10.
12. Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM et al. Risk factors for pulmonary embolism: the Framingham Study. Am J Med 1983;74: 1023-8.
13. Kucher N, Koo S, Quiroz R, Cooper JM, Patemo MD, Soukonnikov B et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352:96-77.
14. Tooher R, Middleton P, Pham C, Fitridge R, Rowe S, Babidge W et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241:397-415.
15. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects [monograph on the internet]. Adopted 1964, last amended 2004 [cited 2007 Sep 30]. Available from: http://www.wma.net/e/policy/b3.htm.
16. Amin A, Stemkowski S, Lin J, et al. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 2007;5:1610-6.
17. Kahn SR, Panju A, Geerts W, et al for the CURVE study investigators. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007;119:145-55.
18. Tapson VF, Decousus H, Pini M, et al for the IMPROVE investigators. Venous thromboembolism prophylaxis in acutely ill hospitalised medical patients: results from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007;132:936-45.
19. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM 2000;93:359-64.
20. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007;146:278-88.
21. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1476-86.
22. Gladding P, Larsen F, Durrant H, Black P. Education together with a preprinted sticker improves the prescribing of prophylactic enoxaparin. N Z Med J 2007;120:2461-70.
23. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-394.